AI Proteins

Delighted to see additional press coverage of @aiproteins.com' recently announced partnership with Astellas If you haven't seen it yet, check out this great article in Fierce Biotech 👇 www.fiercebiotech.com/biotech/aste...

We signed a new research collaboration and license agreement! @aiproteins.com will design and optimize de novo #miniproteins to multiple targets, and Astellas Pharma will do development & commercialization. This division of labor will help get new medicines to patients with the urgency they deserve.

@aiproteins.com has entered a research collaboration and license agreement with Astellas Pharma to discover and develop de novo #miniprotein therapeutics Read the full announcement 👇 www.businesswire.com/news/home/20...

Researchers from @aiproteins.com introduce a streamlined workflow that could reshape how labs produce proteins at scale. The method tackles key bottlenecks across the entire protein production pipeline and is designed to be fully compatible with automation. Read more: zurl.co/kAHMW

We always strive for our work to substantially benefit the greater scientific community, and it's such a thrill every time it happens. A massive thank you to @addgene.bsky.social for amplifying the impact of researchers everywhere! 🧵👇

🧬 Figure Friday AI is making protein design faster, but can protein production keep up? Edson Noriega, Chris Bahl & colleagues developed a high-throughput workflow for rapid protein purification, demonstrated across 96 diverse proteins.

📄 Facile, high-throughput protein purification enabled by high-efficiency protease elution (Fig. 2) Read more here: onlinelibrary.wiley.com/doi/10.1002/...

Power up your protein purification with a new SUMO protease construct from @cdbahl.com and team! Find individual plasmids here: www.addgene.org/browse/artic... Or get the full benchmark set: www.addgene.org/kits/bahl-su...

The data, code, and detailed protocols are all available on github github.com/aiproteins/h... and all the plasmids are available on addgene www.addgene.org/233685/ www.addgene.org/233686/ www.addgene.org/kits/bahl-su...

Science is a team sport, and this project had an amazing team: Edson Cárcamo, Ian Truebridge, Frank Teets, James Bowman, Nathalia Rodriguez, and Tessa Howard

Every protein designer knows that producing & testing designed proteins is a foundational capability for our field, & this is still pretty challenging for a lot of folks. This is why I'm delighted to share our work to make high-throughput protein production more accessible dx.doi.org/10.1002/pro....

Last week’s course was a big success, thanks to our guest speakers! Dane Wittrup @mitkochinstitute.bsky.social, Surge Biswas at Nabla Bio & Justin Peruzzi @aiproteins.com shared insights on yeast display, AI Ab design & miniprotein discovery. Sign up for future course updates ➡️ buff.ly/tTcDWZk

Three weeks ago, we welcomed the local scientific community to join us at our headquarters in Kenmore Square for the inaugural lecture in the AI Proteins Seminar Series. Our speaker Neil King from @uwproteindesign.bsky.social delivered a superb seminar. Check it out 👇 youtu.be/OPRMfRnlx1k

⏰ Tomorrow! Join our webinar, Introduction to Protein Design for Africa, featuring speakers from AI Proteins, STEAMulater, Minimal Bio, and Nostrum Biodiscovery. Learn how protein design is advancing innovation and accessibility around the world! Register: us06web.zoom.us/webinar/regi...

Thank you to everyone who attended the inaugural lecture in the AI Proteins Seminar Series today. Neil King @kinglabipd.bsky.social gave a fantastic talk to a packed house!

Really fun and challenging (!) discussion with @cdbahl.com on BindCraft, the state of binder design, the oustanding challenges and perhaps also some misconceptions in the field 💫 www.healthtech.com/the-chain/ma...

🚨 BIG News: PS40 will include an exclusive visit to AI Proteins HQ! 🎟️ RSVP opens mid-May (first come, first served) 💸 Free for attendees | 🚗 Travel not provided Learn more about AI Proteins from CEO Chris Bahl: “The secret language of cells—and how to ‘speak’ it” www.ted.com/talks/chris_...

Our team is growing! We’re hiring for two new roles on our Biochemistry and Protein Characterization teams. These are hands-on, wet lab positions ideal for early-career scientists eager to make an impact and contribute to cutting-edge drug design. www.aiproteins.com/careers

We're recruiting a Research Associate to join our Bioprocess Development team. This is a wet lab role ideally suited for someone graduating college this spring who is excited to join a team pioneering a new therapeutic modality Check it out! 👇 www.aiproteins.com/open-positio...

I had a great time nerding out about protein design with @nickpolizzi.bsky.social, and an enormous thanks to @biotechtv.bsky.social and @massbio.bsky.social for hosting us! www.biotechtv.com/post/chris-b...

Thanks for the fun conversation Ingmar Schuster, and for the opportunity to share more about what we're building at @aiproteins.com! youtu.be/7O0s5AY46U0

AI Proteins has closed a $41.5 million Series A financing to accelerate the development of de novo #miniproteins! The round was led by Mission BioCapital and SANTÉ, with robust participation from existing investors. See the official press release for details: www.businesswire.com/news/home/20...

The next chapter for AI Proteins @aiproteins.com is officially underway! I'm absolutely delighted to share that we’ve closed a $41.5M Series A led by Mission BioCapital and Santé Ventures. endpoints.news/boston-biote...

This is the foundation for our next chapter at @aiproteins.com. We’ve industrialized the process of creating #miniproteins de novo while fully controlling every aspect of their activity and properties.

My new @ted.com talk from the main stage just went live! go.ted.com/chrisbahl 🧵👇

We're #hiring a Scientist in Mass Spectrometry! Apply today or share this post with your network: www.linkedin.com/jobs/view/42... (ignore what linkedin says - the search is still open) Interested? Please email your CV to: careers@aiproteins.bio

I am overjoyed to announce that James Bowman has been promoted to Chief Technology Officer at @aiproteins.com! 🧵👇

#IPISeminar alert 🔔 Friday at 2 p.m. ET, Chris Bahl of AI Proteins will share the challenges of incorporating #artificialintelligence into #proteindesign & the impact reimagined #miniproteins can have on therapeutics. Join us through the QR code or follow the Zoom link on our calendar! rb.gy/xcee9l

It was an honor to speak from the main stage at TED last week about our work at AI Proteins Our mission is to design the next generation of therapeutics built from de novo #miniproteins, and this was an unbelievable opportunity to help shape the broader conversation about the future of biologics

Welcome Phil Brandish, Chief Development Officer, to the AI Proteins team! www.businesswire.com/news/home/20...

We're delighted to share that our #Founder Chris Bahl @cdbahl.bsky.social is now our CEO!

So, I might have ended up on the jumbotron at the Celtics game proudly wearing my @aiproteins.bsky.social colors

Mireia Solà Colom, Head of Immunotherapeutics at AI Proteins, presents our latest progress on the design and optimization of immune cell engagers built from our de novo #miniproteins

Exciting times at @aiproteins.bsky.social ! We are getting so close to see our drugs helping patients! www.fiercebiotech.com/biotech/bris...

We've got some very exciting news to share! businesswire.com/news/home/20... and here's a 🧵 about the journey from academia to @aiproteins.bsky.social

We're excited that Mireia Solà Colom, our Head of Immunotherapeutics will share some of our latest work on immune cell engagers at @bpdmc.bsky.social next month!

Our founder, President and CSO Chris Bahl @cdbahl.bsky.social went to the Falling Walls Science Summit last week to explain how we make #miniprotein therapeutics with unprecedented ability to control cellular behavior - you can check out the recording 👇 www.youtube.com/live/zB6-iUB...